$Hims & Hers Health Inc.(HIMS)$$DEFIANCE DAILY TARGET 2X LONG HIMS ETF(HIMZ)$ 🚀💊💰 Hims & Hers: The Telehealth Upstart Riding the GLP-1 Wave to New Highs 💰💊🚀 📈 YTD Performance +126% and Climbing I’m watching $HIMS defy gravity in 2025. While broader markets wobble under geopolitical and inflation pressure, this telehealth disruptor has surged on the back of one clear trend: the GLP-1 weight-loss revolution. The stock is now pushing into a critical breakout zone near 60.55, positioning itself as a stealth GLP-1 play alongside the pharmaceutical titans. 💊 Strategic Product Expansion Keeps It in the Game Hims & Hers’ compounded semaglutide offering allows it to sidestep traditional drug pricing s